Nuo Therapeutics Inc
Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospita… Read more
Market Cap & Net Worth: Nuo Therapeutics Inc (AURX)
Nuo Therapeutics Inc (OTCQB:AURX) has a market capitalization of $72.12 Million ($72.12 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #23547 globally and #8211 in its home market, demonstrating a 11.11% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nuo Therapeutics Inc's stock price $1.50 by its total outstanding shares 48077745 (48.08 Million).
Nuo Therapeutics Inc Market Cap History: 2017 to 2025
Nuo Therapeutics Inc's market capitalization history from 2017 to 2025. Data shows change from $6.25 Million to $72.12 Million (-3.47% CAGR).
Nuo Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nuo Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
35.92x
Nuo Therapeutics Inc's market cap is 35.92 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $6.25 Million | $721.04K | -$14.98 Million | 8.67x | N/A |
| 2018 | $1.92 Million | $1.37 Million | -$1.54 Million | 1.40x | N/A |
| 2019 | $5.77 Million | $146.18K | -$1.19 Million | 39.47x | N/A |
| 2020 | $21.63 Million | $4.90K | -$90.87K | 4415.30x | N/A |
| 2022 | $72.12 Million | $112.25K | -$3.17 Million | 642.46x | N/A |
| 2023 | $26.44 Million | $608.52K | -$3.17 Million | 43.45x | N/A |
| 2024 | $49.04 Million | $1.37 Million | -$2.32 Million | 35.92x | N/A |
Competitor Companies of AURX by Market Capitalization
Companies near Nuo Therapeutics Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Nuo Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Nuo Therapeutics Inc Historical Marketcap From 2017 to 2025
Between 2017 and today, Nuo Therapeutics Inc's market cap moved from $6.25 Million to $ 72.12 Million, with a yearly change of -3.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $72.12 Million | +47.06% |
| 2024 | $49.04 Million | +85.45% |
| 2023 | $26.44 Million | -63.33% |
| 2022 | $72.12 Million | +1499900.00% |
| 2021 | $4.81K | -99.98% |
| 2020 | $21.63 Million | +275.00% |
| 2019 | $5.77 Million | +200.00% |
| 2018 | $1.92 Million | -69.23% |
| 2017 | $6.25 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Nuo Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $72.12 Million USD |
| MoneyControl | $72.12 Million USD |
| MarketWatch | $72.12 Million USD |
| marketcap.company | $72.12 Million USD |
| Reuters | $72.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.